87 related articles for article (PubMed ID: 6134794)
1. Studies of carbon-13 n.m.r. spectroscopy in pharmaceutical analysis: the composition of commercial samples of gentamicin sulphate.
Kountourellis J; Parfitt RT; Casy AF
J Pharm Pharmacol; 1983 May; 35(5):279-83. PubMed ID: 6134794
[TBL] [Abstract][Full Text] [Related]
2. Determination of the composition of gentamicin sulfates by 1H and 13C nuclear magnetic spectroscopy.
Busson R; Claes PJ; Vanderhaeghe H
J Assoc Off Anal Chem; 1986; 69(4):601-8. PubMed ID: 3745084
[TBL] [Abstract][Full Text] [Related]
3. Control of the composition of gentamicin sulphate by proton magnetic resonance spectrometry.
Calam DH; Gilbert JN; Lightbown JW; Powell JW; Thomas AH
J Pharm Pharmacol; 1978 Apr; 30(4):220-3. PubMed ID: 24708
[TBL] [Abstract][Full Text] [Related]
4. Determination of the component ratio of commercial gentamicins by high-performance liquid chromatography using pre-column derivatization.
Claes PJ; Busson R; Vanderhaeghe H
J Chromatogr; 1984 Aug; 298(3):445-57. PubMed ID: 6490777
[TBL] [Abstract][Full Text] [Related]
5. Chemical ionization and field desorption mass spectrometry of the gentamicins.
Games DE; Rossiter M; Rogers MS; Weston A; Parfitt RT
Biomed Mass Spectrom; 1976 Oct; 3(5):232-4. PubMed ID: 974239
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity of the constituents of the gentamicin complex.
Kohlhepp SJ; Loveless MO; Kohnen PW; Houghton DC; Bennett WM; Gilbert DN
J Infect Dis; 1984 Apr; 149(4):605-14. PubMed ID: 6725992
[TBL] [Abstract][Full Text] [Related]
7. Isolation and structure characterization of related impurities in etimicin sulfate by LC/ESI-MS(n) and NMR.
Wang H; Zhang Z; Xiong F; Wu L; Li P; Ye W
J Pharm Biomed Anal; 2011 Jul; 55(5):902-7. PubMed ID: 21444173
[TBL] [Abstract][Full Text] [Related]
8. Gentamicin assay in human serum by solid-phase extraction and capillary electrophoresis.
Kaale E; Long Y; Fonge HA; Govaerts C; Desmet K; Van Schepdael A; Hoogmartens J
Electrophoresis; 2005 Feb; 26(3):640-7. PubMed ID: 15690437
[TBL] [Abstract][Full Text] [Related]
9. Variations in gentamicin C1, C1a, C2, and C2a content of some preparations of gentamicin sulphate used clinically as determined by high-performance liquid chromatography.
White LO; Lovering A; Reeves DS
Ther Drug Monit; 1983; 5(1):123-6. PubMed ID: 6845395
[No Abstract] [Full Text] [Related]
10. Preparative purification of gentamicin components using high-speed counter-current chromatography coupled with electrospray mass spectrometry.
Inoue K; Hattori Y; Horie M; Hino T; Oka H
J Sep Sci; 2011 Jun; 34(12):1484-8. PubMed ID: 21548130
[TBL] [Abstract][Full Text] [Related]
11. An LC-MS/MS based candidate reference method for the quantification of total gentamicin in human serum and plasma using NMR characterized calibrator material.
Lucha S; Taibon J; Pongratz S; Geletneky C; Huber E; Wintterle-Roehm C; Lang R; Grimm SH; Duelffer T; Tarasov K; Zander J; Vogeser M; Kobold U
Clin Chim Acta; 2017 Jan; 464():211-217. PubMed ID: 27871844
[TBL] [Abstract][Full Text] [Related]
12. Determination of gentamicin in swine and calf tissues by high-performance liquid chromatography combined with electrospray ionization mass spectrometry.
Cherlet M; Baere SD; Backer PD
J Mass Spectrom; 2000 Nov; 35(11):1342-50. PubMed ID: 11114094
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan sidechain dynamics in hydrophobic oligopeptides determined by use of 13C nuclear magnetic resonance spectroscopy.
Weaver AJ; Kemple MD; Prendergast FG
Biophys J; 1988 Jul; 54(1):1-15. PubMed ID: 3416021
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a novel LC/ELSD method for the quantitation of gentamicin sulfate components in pharmaceuticals.
Megoulas NC; Koupparis MA
J Pharm Biomed Anal; 2004 Sep; 36(1):73-9. PubMed ID: 15351050
[TBL] [Abstract][Full Text] [Related]
15. Analysis of underivatized gentamicin by capillary electrophoresis with UV detection.
Curiel H; Vanderaerden W; Velez H; Hoogmartens J; Van Schepdael A
J Pharm Biomed Anal; 2007 May; 44(1):49-56. PubMed ID: 17314024
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of liquid chromatography tandem mass spectrometry methods for the determination of gentamicin, lincomycin, and spectinomycin in the presence of their impurities in pharmaceutical formulations.
Vučićević-Prčetić K; Cservenák R; Radulović N
J Pharm Biomed Anal; 2011 Dec; 56(4):736-42. PubMed ID: 21839597
[TBL] [Abstract][Full Text] [Related]
17. Direct determination of gentamicin components by capillary electrophoresis with potential gradient detection.
Yuan L; Wei H; Li SF
Electrophoresis; 2005 Jan; 26(1):196-201. PubMed ID: 15624170
[TBL] [Abstract][Full Text] [Related]
18. Forensic investigation of gentamicin sulfates by anion-exchange ion chromatography with pulsed electrochemical detection.
Kaine LA; Wolnik KA
J Chromatogr A; 1994 Jul; 674(1-2):255-61. PubMed ID: 8075773
[TBL] [Abstract][Full Text] [Related]
19. 1H- and 13C-n.m.r. studies of the antitumour antibiotic luzopeptin. Resonance assignments, conformation and flexibility in solution.
Searle MS; Hall JG; Wakelin PG
Biochem J; 1988 Nov; 256(1):271-8. PubMed ID: 3223903
[TBL] [Abstract][Full Text] [Related]
20. DNA duplex dynamics: NMR relaxation studies of a decamer with uniformly 13C-labeled purine nucleotides.
Kojima C; Ono A; Kainosho M; James TL
J Magn Reson; 1998 Dec; 135(2):310-33. PubMed ID: 9878461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
